成人高血压筛查:美国预防服务工作组更新证据报告与系统综述
该系统综述纳入52项研究(N=215 534),评估成人高血压筛查及确诊测量的获益与危害。办公室血压筛查的汇总敏感性0.54、特异性0.90;办公室确诊敏感性0.80、特异性0.55;家庭确诊敏感性0.84、特异性0.60;动态血压监测与暂时睡眠障碍和瘀伤相关。筛查直接危害最小,但诊断准确性有限,需确定最佳筛查与确诊流程。
要点
- 办公室初始血压筛查敏感性低(0.54),特异性高(0.90),存在误诊可能。
- 办公室确诊测量敏感性0.80、特异性0.55;家庭确诊敏感性0.84、特异性0.60。
- 筛查未见生活质量或心理困扰下降,动态血压监测有暂时睡眠障碍和瘀伤。
核心结论
- 办公室血压筛查准确性有限,存在误诊风险,但测量直接危害最小。
- 需研究确定临床实践中最佳筛查与确诊流程。
研究设计与样本
- 系统综述纳入52项研究,总样本量215 534人,检索MEDLINE、PubMed、Cochrane CENTRAL和CINHAL至2021年3月26日。
- 纳入随机对照试验、非随机对照干预研究评估筛查有效性,诊断准确性研究评估筛查与确诊测量,观察性研究评估危害。
主要发现
- 一项整群随机对照试验(n=140 642)显示,包含高血压筛查的多组分干预组每年心血管病相关住院少于对照组(每1000人差异3.02,率比0.91,95%CI 0.86-0.97)。
- 15项办公室初始血压筛查研究的荟萃分析(n=11 309)显示汇总敏感性0.54(95%CI 0.37-0.70),特异性0.90(95%CI 0.84-0.95),异质性较大。
- 8项办公室确诊测量研究的荟萃分析(n=53 183)显示汇总敏感性0.80(95%CI 0.68-0.88),特异性0.55(95%CI 0.42-0.66)。
- 4项家庭确诊测量研究的荟萃分析(n=1001)显示汇总敏感性0.84(95%CI 0.76-0.90),特异性0.60(95%CI 0.48-0.71)。
临床怎么用
- 办公室血压筛查可用于初步识别,但需注意其低敏感性可能导致漏诊。
- 确诊高血压时可考虑家庭血压监测,其敏感性较高但特异性中等。
- 动态血压监测可能引起暂时睡眠障碍和瘀伤,应向患者说明。
局限性
- 筛查与确诊测量研究间存在显著的临床和统计学异质性。
- 缺勤相关证据混杂,无法得出明确结论。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Hypertension is a major risk factor for cardiovascular disease and can be modified through lifestyle and pharmacological interventions to reduce cardiovascular events and mortality. OBJECTIVE: To systematically review the benefits and harms of screening and confirmatory blood pressure measurements in adults, to inform the US Preventive Services Task Force. DATA SOURCES: MEDLINE, PubMed, Cochrane Collaboration Central Registry of Controlled Trials, and CINAHL; surveillance through March 26, 2021. STUDY SELECTION: Randomized clinical trials (RCTs) and nonrandomized controlled intervention studies for effectiveness of screening; accuracy studies for screening and confirmatory measurements (ambulatory blood pressure monitoring as the reference standard); RCTs and nonrandomized controlled intervention studies and observational studies for harms of screening and confirmation. DATA EXTRACTION AND SYNTHESIS: Independent critical appraisal and data abstraction; meta-analyses and qualitative syntheses. MAIN OUTCOMES AND MEASURES: Mortality; cardiovascular events; quality of life; sensitivity, specificity, positive and negative predictive values; harms of screening. RESULTS: A total of 52 studies (N = 215 534) were identified in this systematic review. One cluster RCT (n = 140 642) of a multicomponent intervention including hypertension screening reported fewer annual cardiovascular-related hospital admissions for cardiovascular disease in the intervention group compared with the control group (difference, 3.02 per 1000 people; rate ratio, 0.91 [95% CI, 0.86-0.97]). Meta-analysis of 15 studies (n = 11 309) of initial office-based blood pressure screening showed a pooled sensitivity of 0.54 (95% CI, 0.37-0.70) and specificity of 0.90 (95% CI, 0.84-0.95), with considerable clinical and statistical heterogeneity. Eighteen studies (n = 57 128) of various confirmatory blood pressure measurement modalities were heterogeneous. Meta-analysis of 8 office-based confirmation studies (n = 53 183) showed a pooled sensitivity of 0.80 (95% CI, 0.68-0.88) and specificity of 0.55 (95% CI, 0.42-0.66). Meta-analysis of 4 home-based confirmation studies (n = 1001) showed a pooled sensitivity of 0.84 (95% CI, 0.76-0.90) and a specificity of 0.60 (95% CI, 0.48-0.71). Thirteen studies (n = 5150) suggested that screening was associated with no decrement in quality of life or psychological distress; evidence on absenteeism was mixed. Ambulatory blood pressure measurement was associated with temporary sleep disturbance and bruising. CONCLUSIONS AND RELEVANCE: Screening using office-based blood pressure measurement had major accuracy limitations, including misdiagnosis; however, direct harms of measurement were minimal. Research is needed to determine optimal screening and confirmatory algorithms for clinical practice.
引用
- Guirguis-Blake JM, Evans CV, Webber EM, et al. Screening for Hypertension in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2021. PMID: 33904862. doi:10.1001/jama.2020.21669
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。